基于分子对接及体外抑制实验预测芹菜素潜在药物相互作用Prediction of potential drug interactions of apigenin based on molecular docking and in vitro inhibition experiments
汪祺;王亚丹;杨建波;刘越;文海若;马双成;
WANG Qi;WANG Ya-dan;YANG Jian-bo;LIU Yue;WEN Hai-ruo;MA Shuang-cheng;National Institutes for Food and Drug Control;
摘要(Abstract):
该研究旨在考察芹菜素对UGT1A1酶活性的影响,从而预测其在临床用药时潜在的药物间相互作用。实验拟在前期实验基础上,首先采用计算机分子对接手段初步预测芹菜素与UGT1A1酶的结合靶点及结合强弱;其次采用体外人肝微粒体温孵体系,评价其对UGT1A1酶是否具有抑制作用。分子对接显示芹菜素对接进入UGT1A1酶蛋白F活性区,与内源性物质胆红素对接活性区重合,亲和作用中等;芹菜素黄酮母核主要与氨基酸残基ILE343和VAL345形成疏水结合Pi-Alkyl作用,同时,母核上羟基与氨基酸残基LYS346形成了额外的氢键作用,增加了分子与蛋白的结合。提示黄酮类母核结构具有与酶蛋白UGT1A1结合的特殊结构,同时母核引入羟基可增加结合能力。体外抑制实验提示芹菜素对UGT1A1酶具有中等抑制作用,抑制类型为竞争型抑制,与分子对接结果一致。综合两部分实验内容表明,芹菜素为UGT1A1酶底物,可竞争型抑制酶活性,临床用药中与UGT1A1酶底物具有药物间相互作用的风险。
The purpose of this study was to investigate the effect of apigenin on UGT1 A1 enzyme activity and to predict the potential drug-drug interaction of apigenin in clinical use. First,on the basis of previous experiments,the binding targets and binding strength of apigenin to UGT1 A1 enzyme were predicted by computer molecular docking method. Then the inhibitory effect of apigenin on UGT1 A1 enzyme was evaluated by in vitro human liver microsomal incubation system. Molecular docking results showed that apigenin was docked into the active region of UGT1 A1 enzyme protein F,consistent with the active region of bilirubin docking,with moderate affinity. Apigenin flavone mother nucleus mainly interacted with amino acid residues ILE343 and VAL345 to form hydrophobic binding Pi-Alkyl. At the same time,the hydroxyl group on the mother nucleus and the amino acid residue LYS346 formed an additional hydrogen bond,which increased the binding of the molecule to the protein. These results suggested that the flavonoid mother nucleus structure had a special structure binding to the enzyme protein UGT1 A1,and the introduction of hydroxyl groups into the mother nucleus can increase the binding ability. In vitro inhibition experiments showed that apigenin had a moderate inhibitory effect on UGT1 A1 enzyme in a way of competitive inhibition,which was consistent with the results of molecular docking. The results of two experiments showed that apigenin was the substrate of UGT1 A1 enzyme,which could inhibit the activity of UGT1 A1 enzyme competitively,and there was a risk of drug interaction between apigenin and UGT1 A1 enzyme substrate in clinical use.
关键词(KeyWords):
芹菜素;UGT1A1酶;分子对接;人肝微粒体;药物相互作用
apigenin;UGT1A1 enzyme;molecular docking;human microsome livers;drug-drug interaction(DDI)
基金项目(Foundation): 国家自然科学基金项目(81503347)
作者(Authors):
汪祺;王亚丹;杨建波;刘越;文海若;马双成;
WANG Qi;WANG Ya-dan;YANG Jian-bo;LIU Yue;WEN Hai-ruo;MA Shuang-cheng;National Institutes for Food and Drug Control;
DOI: 10.19540/j.cnki.cjcmm.20190326.401
参考文献(References):
- [1]文赤夫,董爱文,罗庆华,等.紫花地丁中芹菜素提取和清除自由基活性研究[J].现代食品科技,2006,22(1):20.
- [2]陈亭亭,杨培伟,张树辉.芹菜素抗肿瘤机制的研究进展[J].中国现代应用药学,2019,36(4):507.
- [3]隋海霞,徐海滨,荫士安.芹菜素的生物学作用[J].国外医学·卫生学分册,2008,35(2):103.
- [4]黄链莎,刘铜华,孙文,等.芹菜素对肥胖型小鼠脂肪组织AMPK信号通路的作用机制[J].中国实验方剂学杂志,2018,24(10):107.
- [5]张娇,王元忠,杨维泽,等.黄精属植物化学成分及药理活性研究进展[J].中国中药杂志,2019,44(10):1989.
- [6]任蜜蜜,夏滢,冯紫薇,等.基于2D-TLC与HPLC-IT-TOF-MS联用技术的雪菊黄酮部位化学成分分析[J].中国中药杂志,2019,44(7):1403.
- [7] Chen Y,Jia X B,Chen J,et al. The pharmacokinetics of raloxifene and its interaction with apigenin in rat[J]. Molecules,2010,15(11):8478.
- [8] Xu Y M,Xin Y Q,Diao Y,et al. Synergistic effects of apigenin and paclitaxel on apoptosis of cancer cells[J]. PLoS ONE,2011,6(12):e29169.
- [9] Lee I A,Sang K H,Cho E J,et al. Resveratrol as a bioenhancer to improve anti-inflammatory activities of apigenin[J]. Nutrients,2015,7(11):9650.
- [10] Liu X,Tam V H,Hu M. Disposition of flavonoids via enteric recycling:determination of the UDP-glucuronosyltransferase(UGT)isoforms responsible for the metabolism of flavonoids in intact Caco-2 TC7 cells using siRNA[J]. Mol Pharm,2007,4(6):873.
- [11] King C D,Rios G R,Green M D,et al. UDP-glucuronosyltransferase[J]. Curr Drug Metab,2000,1:143.
- [12] Ruefer C E,Gerhauser C,Frank N,et al. In vitro phaseⅡmetabolism of xanthohumol by human UDP-glucuronosyltrasferases and sulfotransferases[J]. Mol Nutr Food Res,2005,49:851.
- [13] Wang Q,Wang Y D,Li Y,et al. Identification and characterization of the structure-activity relationships involved in UGT1A1inhibition by anthraquinone and dianthrone constituents of Polygonum multiflorum[J]. Sci Rep-UK,2017,7:17592.
- [14]汪祺,戴忠,张玉杰,等.何首乌中二蒽酮类成分肝毒性研究[J].药物分析杂志,2018,38(2):268.
- [15]汪祺,戴忠,张玉杰,等.基于二相代谢酶介导胆红素代谢考察不同体系UGT1A1酶动力学参数[J].中国药学杂志,2015,50(19):56.
- [16]汪祺,戴忠,张玉杰,等.基于UGT1A1酶介导的胆红素代谢考察大黄素在肝微粒体体系中的肝毒性[J].中国中药杂志,2016,41(23):4424.
- [17] Zeng M,Sun R J,Basu S,et al. Disposition of flavonoids via recycling:direct biliary excretion of enterically or extrahepatically derived flavonoid glucuronides[J]. Mol Nutr Food Res,2016,60(5):1006.
- [18]袁杨,耿璐璐,庄贺飞,等.芫花致肝毒性部位筛选及其肝毒性部位UPLC指纹图谱研究[J].中国中药杂志,2013,38(1):70.
- [19]郭嫦娥,苗培培,陈红影,等.芫花醇提物对不同种属体系UGTs及UGT1A1活性的影响[J].中国中医药信息杂志,2017,24(4):83.
- 芹菜素
- UGT1A1酶
- 分子对接
- 人肝微粒体
- 药物相互作用
apigenin - UGT1A1 enzyme
- molecular docking
- human microsome livers
- drug-drug interaction(DDI)
- 汪祺
- 王亚丹
- 杨建波
- 刘越
- 文海若
- 马双成
WANG Qi- WANG Ya-dan
- YANG Jian-bo
- LIU Yue
- WEN Hai-ruo
- MA Shuang-cheng
- National Institutes for Food and Drug Control
- 汪祺
- 王亚丹
- 杨建波
- 刘越
- 文海若
- 马双成
WANG Qi- WANG Ya-dan
- YANG Jian-bo
- LIU Yue
- WEN Hai-ruo
- MA Shuang-cheng
- National Institutes for Food and Drug Control